Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685070 | SCV000812542 | pathogenic | Charcot-Marie-Tooth disease, type I | 2019-07-11 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with proline at codon 16 of the PMP22 protein (p.Leu16Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change results in an unstable, improperly folded and mislocalized protein (PMID: 26102530, 18795802, 21827951, 25385046, 9425015). Furthermore, mouse models with this missense change recapitulate the human phenotype (PMID: 6313869, 12090404). This variant has been reported to be de novo in an individual affected with Charcot-Marie-Tooth disease, type 1 (CMT1) (PMID: 8995589) and has been reported to segregate with CMT1 in affected families (PMID: 8995589, 1303281). It has also been reported in an unrelated individual affected with CMT1 (PMID: 23689413). ClinVar contains an entry for this variant (Variation ID: 8428). |
OMIM | RCV000008940 | SCV000029150 | pathogenic | Charcot-Marie-Tooth disease, type IA | 1993-05-01 | no assertion criteria provided | literature only | |
Gene |
RCV000008940 | SCV000055666 | not provided | Charcot-Marie-Tooth disease, type IA | no assertion provided | literature only |